Nonmedical economic consequences attributable to visual impairment Antoine LafumaAntoine BrezinGilles Berdeaux Original Papers Pages: 158 - 164
A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany Stephen M. BeardFiona MaciverEckart Rüther Original papers Pages: 165 - 172
Test-retest reliability of willingness to pay Alan ShiellPenelope Hawe Original Papers Pages: 173 - 178
The costs of schizophrenia in Spain Juan Oliva-MorenoJulio López-BastidaBeatriz Duque-González Original Papers Pages: 179 - 184
Problems and costs associated with alcohol and drug abuse in emergency medicine F.-X. HuberT. HackertP. J. Meeder Original Papers Pages: 192 - 194
Determinants of household health expenditure on western institutional health care Tin Tin SuSubhash PokhrelSteffen Flessa Original papers Pages: 195 - 203
Price regulation and generic competition in the pharmaceutical market Dag Morten DalenSteinar StrømTonje Haabeth Original Papers Pages: 204 - 211
Alcohol-related mortality, drinking behavior, and business cycles Edvard JohanssonPetri BöckermanAntti Uutela Original Papers Pages: 212 - 217
Decision models in the evaluation of psychotropic drugs Corrado BarbuiCamilla Lintas Original Papers Pages: 218 - 220